1. Home
  2. ZGM vs CTXR Comparison

ZGM vs CTXR Comparison

Compare ZGM & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZGM

Zenta Group Company Limited Ordinary Shares

N/A

Current Price

$1.65

Market Cap

18.3M

ML Signal

N/A

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.82

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZGM
CTXR
Founded
2019
2007
Country
Macau
United States
Employees
9
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
18.9M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ZGM
CTXR
Price
$1.65
$0.82
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
10.3K
434.4K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.38
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.57
P/E Ratio
$20.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$0.63
52 Week High
$4.44
$2.38

Technical Indicators

Market Signals
Indicator
ZGM
CTXR
Relative Strength Index (RSI) 51.33 50.39
Support Level $1.38 $0.66
Resistance Level $1.87 $0.98
Average True Range (ATR) 0.17 0.07
MACD 0.02 0.00
Stochastic Oscillator 71.79 52.80

Price Performance

Historical Comparison
ZGM
CTXR

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is a professional services provider in Macau, offering industrial park consulting services, business investment consulting services through LIC, and the sale of fintech products and services through LFT. Its industrial park consulting services focus on the pre-development stage, assisting with applications and negotiations for industrial park projects with PRC government authorities, with plans to expand into post-development services through LMS. The business investment consulting services mainly involve assisting clients in acquiring equity stakes in technology firms, private equity management firms, and industrial park project firms, supported by third-party professionals. The Group operates in Macau and the PRC, generating the majority of its revenue from the PRC.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: